Philip Buck, PhD, MPH

Moderna, Inc.

Disclosure(s): Moderna, Inc.: Salary, Stocks/Bonds

Poster(s):

• 116 - Potential Clinical Impact of Respiratory Syncytial Virus (RSV) Vaccination in Older Adults in the United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1458 - Epidemiology of Infectious Mononucleosis in Ambulatory Care Settings, United States, 2006–2019
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 2145 - Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET